ABO antigen-specific immunoadsorption was discontinued in 5/6 (83%) patients when reticulocyte counts increased to levels ≥80 G/L, suggesting the resolution of PRCA (Figure 1). The gene discussed is ABO; the disease is pure red-cell aplasia.